Clinical trials recruiting for Relapsed Small Cell Lung Cancer
3
Recruiting trials
10
US states with sites
2
Countries
33%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Lurbinectedin | 2 |
| Topotecan | 2 |
| Irinotecan | 1 |
| Irinotecan hydrochloride liposome injection | 1 |
| Stenoparib/Temozolomide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kentucky | 1 |
| Michigan | 1 |
| Minnesota | 1 |
| Nebraska | 1 |
| North Carolina | 1 |
| Pennsylvania | 1 |
| Texas | 1 |
Top cities
Ann Arbor, Michigan 1Chicago, Illinois 1Houston, Texas 1Indianapolis, Indiana 1Louisville, Kentucky 1Minneapolis, Minnesota 1Omaha, Nebraska 1Palo Alto, California 1Philadelphia, Pennsylvania 1Pittsburgh, Pennsylvania 1
Self-screener
Recruiting trials
- Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
- Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer
Related conditions
Trials recruiting for Relapsed Small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Relapsed Small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.